ATP13A2 anticorps (Internal Region)
-
- Antigène Voir toutes ATP13A2 Anticorps
- ATP13A2 (ATPase Type 13A2 (ATP13A2))
-
Épitope
- AA 200-300, Internal Region
-
Reactivité
- Humain, Souris
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp ATP13A2 est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC)
- Specificité
- Reacts with human and mouse ~129 kDa ATP13A2 protein
- Purification
- Antigen affinity purified
- Immunogène
- Synthetic peptide within the internal region of residues 200-300 of the human ATP13A2 protein
- Top Product
- Discover our top product ATP13A2 Anticorps primaire
-
-
- Indications d'application
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
- IHC : 10 to 20 μg/mL - WB : 2 μg/mL - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.75 mg/mL
- Buffer
- Tris-glycine, NaCl 150 mM buffer, Sodium azide 0.05 %
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C/-80 °C
- Stockage commentaire
- Aliquot and store at -20°C or -80°C. Avoid freeze-thaw cycles.
-
- Antigène
- ATP13A2 (ATPase Type 13A2 (ATP13A2))
- Autre désignation
- Probable Cation-Transporting ATPase 13A2 (ATP13A2 Produits)
- Synonymes
- anticorps ATP13A2, anticorps 1110012E06Rik, anticorps AA589443, anticorps RGD1307977, anticorps im:7147302, anticorps zgc:136762, anticorps CLN12, anticorps HSA9947, anticorps KRPPD, anticorps PARK9, anticorps ATPase 13A2, anticorps ATPase type 13A2, anticorps probable cation-transporting ATPase 13A2, anticorps ATP13A2, anticorps Atp13a2, anticorps atp13a2, anticorps PTRG_01071, anticorps MCYG_01937, anticorps LOC100439053
- Pathways
- Ribonucleoside Biosynthetic Process
-